Usefulness of splenectomy for chronic active antibody-mediated rejection after renal transplantation

Transplant International

Volumn 21, Issue 6, 2008, Pages 602-604

  Ishida, Hideki ^a   Omoto, Kazuya ^a   Shimizu, Tomokazu ^a   Shirakawa, Hiroki ^a   Nishida, Hayato ^a   Xiaobei, Li ^a   Yamaguchi, Yutaka ^b   Tanabe, Kazunari ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BASILIXIMAB; CREATININE; HLA ANTIBODY; IMMUNOGLOBULIN; MEDOROL; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RITUXIMAB; TACROLIMUS;

ACUTE GRAFT REJECTION; ANTIBODY BLOOD LEVEL; ANTIBODY PRODUCTION; ANTIBODY TITER; CASE REPORT; CELL PROLIFERATION; CHRONIC GRAFT REJECTION; CLINICAL EFFECTIVENESS; COMBINATION CHEMOTHERAPY; CREATININE BLOOD LEVEL; DISEASE SEVERITY; DRUG BLOOD LEVEL; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG MEGADOSE; FOLLOW UP; GRAFT RECIPIENT; HUMAN; HUMAN TISSUE; KIDNEY BIOPSY; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LETTER; LIVING DONOR; MEMORY CELL; PATIENT SELECTION; PLASMAPHERESIS; PRIORITY JOURNAL; SENSITIZATION; SPLENECTOMY; TREATMENT OUTCOME;

CHRONIC DISEASE; FEMALE; GRAFT REJECTION; HLA ANTIGENS; HUMANS; ISOANTIBODIES; KIDNEY TRANSPLANTATION; MALE; SPLENECTOMY;

EID: 42649111647     PISSN: 09340874     EISSN: 14322277     Source Type: Journal    
DOI: 10.1111/j.1432-2277.2008.00653.x     Document Type: Letter

References (7)

1. Racusen LC, Colvin RB, Solez K, et al. Antibody mediated rejection criteria- an addition to Banff 1997 classification of renal allograft rejection. Am J Transplant 2003 3 : 708.
2. Ishida H, Miyamoto N, Tanabe K, et al. Evaluation of immunosuppressive regimens in ABO-incompatible living kidney transplantation-single center analysis. Am J Transplant 2007 7 : 825.
3. Becker YT, Becker BN, Pirsch JD, et al. Rituximab as treatment for refractory kidney transplant rejection. Am J Transplant 2004 4 : 996.
4. Sonnenday CJ, Warren DS, Cooper M, et al. Plasmapheresis, CMV hyperimmune globulin, and anti-CD 20 allow ABO-incompatible renal transplantation without splenectomy. Am J Transplant 2004 4 : 1315.
5. Locke JE, Zachary AA, Haas M, et al. The utility of splenectomy as rescue treatment for severe acute antibody mediated rejection. Am J Transplant 2007 7 : 842.
6. Manz RA, Thiel A, Radruch A. Life time of plasma cells in the bone marrow. Nature 1997 388 : 133.
7. O'Connor BP, Cascalho M, Noelle RJ. Short-lived and long-lived bone marrow plasma cells are derived from a novel precursor population. J Exp Med 2002 195 : 737.